NEW YORK–(BUSINESS WIRE)–Daily contact lenses continue to steal share of wallet in the US from weekly lenses, according to the latest data from GfK’s POS Tracking team.
Uncategorized
Uncategorized
From Vision 2020 to universal eye health
According to the World Health Organization, an estimated 285 million people are visually impaired worldwide, with 39 million people who are blind and 246 million people who have low vision. About 80% of all visual impairment can be avoided or cured.In May 2013, the 66th World Health Assembly endorsed the WHO 2014-2019 Global Action Plan (GAP) for the prevention of avoidable blindness and visual impairment. Building upon and replacing Vision 2020, GAP 2014-2019 is now the most important strategic document in eye health. It sets up a clear target to reduce the prevalence of avoidable blindness and visual impairment by 25% by 2019 from baseline data collected in 2010, representing a significant step forward toward “universal eye health.”
Uncategorized
International Study Shows 3-Year Benefits of Glaukos iStent® Trabecular Micro-Bypass Stent in Combination with Cataract Surgery
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that a new international clinical study, published in the Journal of Cataract and Refractive Surgery, showed use of the iStent® Trabecular Micro-Bypass Stent in conjunction with cataract surgery provided a 36% reduction in mean int
Uncategorized
Invitation to Tobii’s Conference Call Following the 2015 Year-End Report
STOCKHOLM–(BUSINESS WIRE)–Regulatory News: Tobii AB (STO:TOBII) plans to publish the year-end report for the period January 1—December 30 on February 16 at 08.00 CET. Following this report Tobii will host a conference call with web cast presentation for investors, analysts and media. Tobii’s President and CEO Henrik Eskilsson and CFO Esben Olesen will present and comment on the report. After the presentation there will be time for questions. The presentation will be held in English. Time Tues
Uncategorized
Corneal inlay with concurrent LASIK may treat presbyopic myopes
There are several presbyopia-correcting corneal inlays on the market in the Asia-Pacific region, and our clinic, a high-volume commercial LASIK practice in Japan, has the most experience with the Raindrop from ReVision Optics. In fact, our center is the most experienced commercial Raindrop clinic in the world. Formerly known as the Vue+ and PresbyLens, the Raindrop is a microscopic hydrogel inlay with a 2-mm diameter and thickness of approximately 30 µm.It is placed under a femtosecond laser flap, and its thin edge allows the cornea to lay flat and seal securely. The Raindrop is comprised of approximately 80% water and therefore has a refractive index similar to the cornea; it also allows free flow of nutrients and oxygen across the cornea. Perhaps most notably, it creates a profocal cornea, ie, near vision on the visual axis with a gradual transition to intermediate and distance vision out to the periphery. Furthermore, because the Raindrop is physiologically transparent, it does not restrict the amount of light reaching the retina and is invisible to the naked eye.
Uncategorized
New frontiers of technology for treatment of eye diseases
Contemporary health care is changing radically as emerging technologies use innovation and creativity to determine newer ways of managing complex problems. The pharmaceutical industry has been on the forefront of invention, creating novel drugs and dru…